FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the field of organic chemistry and pharmaceuticals and is intended for therapy and prevention of metabolic syndrome. Presented is a new compound N-[3-oxolup-28-oyl]-2-(4-(2-(4-((S)2-ethoxy-3-propanoyl)phenoxy)ethyl)phenoxy)ethanamide of the structure 5.
EFFECT: effective lipid and glycemic control.
1 cl, 4 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| (2S)-3-(4-{2-[4-(2-{[(1R,4AR,7S)-7-ETHYNYL-1,4A,7-TRIMETHYL-1,2,3,4,4A,4B,5,6,7,8,10,10A-DODECAHYDROPHENANTHREN-1-YL]FORMAMIDO}ETHOXY)PHENYL]ETHOXY}PHENYL)-2-ETHOXY-PROPANOIC ACID FOR THERAPY AND PREVENTION OF METABOLIC SYNDROME | 2023 |
|
RU2813464C1 |
| MONOTERPENES-SUBSTITUTED (S)-2-ETHOXY-3-(4-(4-HYDROXYPHENETHOXY)-PHENYL)-PROPANOIC ACIDS FOR TREATMENT OF METABOLIC SYNDROME | 2024 |
|
RU2831554C1 |
| NEW DERIVATIVES AND ANALOGUES OF 3-ARYLPROPIONIC ACID | 1999 |
|
RU2243214C2 |
| QUINOLINE-2 DERIVATIVES AS C-KIT KINASE INHIBITORS | 2016 |
|
RU2754858C2 |
| 1-(2-ISOPROPOXYETHYL)-2-THIOXO-1,2,3,5-TETRAHYDRO-PYRROLO[3,2-d]PYRIMIDIN-4-ONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2005 |
|
RU2409578C2 |
| 2-OXINDOLE COMPOUNDS | 2017 |
|
RU2743747C2 |
| DISCLOSED ARE 3,6-DIAMINOPYRIDAZIN-3-YL DERIVATIVES CONTAINING PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS PRO-APOPTOTIC AGENTS | 2020 |
|
RU2830186C2 |
| 3-IMINO-N-ARYL-2-CHLOROFURO[2,3-b]PYRIDINE-2-CARBOXAMIDES AS 2,4-D ANTIDOTES ON SUNFLOWER AND METHOD FOR PRODUCTION THEREOF | 2024 |
|
RU2829740C1 |
| METHOD OF SYNTHESIS OF CIS-1-{2-[4-(6-METHOXY-2-PHENYL-1,2,3,4-TETRAHYDRONAPHTHALENE-1-YL)-PHENOXY]ETHYL}PYRROLIDINE AND INTERMEDIATE COMPOUNDS | 2000 |
|
RU2195445C2 |
| 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES | 2020 |
|
RU2822388C2 |
